Skip to main content
Top
Published in: Journal of Cardiothoracic Surgery 1/2021

Open Access 01-12-2021 | Arterial Occlusive Disease | Research article

LncRNA SCIRT is downregulated in atherosclerosis and suppresses the proliferation of human aortic smooth muscle cells (HAOSMCs) by sponging miR-146a in cytoplasm

Authors: Wenhui Gao, Rong Li, Jingjing Yu, Xijie He, Duo Xu, Hai Zhong, Wenwen Dong, Hanbin Cui

Published in: Journal of Cardiothoracic Surgery | Issue 1/2021

Login to get access

Abstract

Background

SCIRT has been characterized as a key player in cancer biology, while its role in other human diseases is unclear. This study explored its role in atherosclerosis, with a specific focus on its interaction with SCIRT and miR-146a.

Methods

The expression of SCIRT and miR-146a in atherosclerosis-affected tissues and healthy tissues from 56 atherosclerosis patients were analyzed by RT-qPCR. The expression of SCIRT in nuclear and cytoplasm samples was detected by RNA fractionation assay. The direct interaction between SCIRT and miR-146a was detected by RNA pull-down assay. SCIRT and miR-146a were overexpressed in human aortic smooth muscle cells (HAOSMCs) to study the crosstalk between them. The role of SCIRT and miR-146a in the proliferation of HAOSMCs was analyzed with BrdU assay.

Results

SCIRT was downregulated by atherosclerosis, while miR-146a was upregulated by atherosclerosis. SCIRT was detected in both cytoplasm and nuclear samples, and it directly interacted with miR-146a. In HAOSMCs, overexpression of SCIRT and miR-146a did not affect the expression of each other. Interestingly, SCIRT suppressed the proliferation of HAOSMCs and reduced the enhancing effects of miR-146a on cell proliferation.

Conclusion

Therefore, SCIRT is downregulated in atherosclerosis and it suppresses the proliferation of HAOSMCs by sponging miR-146a in cytoplasm.
Literature
1.
go back to reference Geovanini GR, Libby P. Atherosclerosis and inflammation: overview and updates. Clin Sci. 2018;132(12):1243–52.CrossRef Geovanini GR, Libby P. Atherosclerosis and inflammation: overview and updates. Clin Sci. 2018;132(12):1243–52.CrossRef
2.
go back to reference Antoniades C, Kotanidis CP, Berman DS. State-of-the-art review article. Atherosclerosis affecting fat: what can we learn by imaging perivascular adipose tissue? J Cardiovasc Comput Tomogr. 2019;13(5):288–96.CrossRef Antoniades C, Kotanidis CP, Berman DS. State-of-the-art review article. Atherosclerosis affecting fat: what can we learn by imaging perivascular adipose tissue? J Cardiovasc Comput Tomogr. 2019;13(5):288–96.CrossRef
3.
go back to reference Stroes ES, Thompson PD, Corsini A, Vladutiu GD, Raal FJ, Ray KK, et al. Statin-associated muscle symptoms: impact on statin therapy-European Atherosclerosis Society Consensus Panel Statement on Assessment. Aetiol Manag Eur Heart J. 2015;36(17):1012–22.CrossRef Stroes ES, Thompson PD, Corsini A, Vladutiu GD, Raal FJ, Ray KK, et al. Statin-associated muscle symptoms: impact on statin therapy-European Atherosclerosis Society Consensus Panel Statement on Assessment. Aetiol Manag Eur Heart J. 2015;36(17):1012–22.CrossRef
4.
go back to reference Venegas-Pino DE, Lagrotteria A, Wang PW, Morphet J, Clapdorp C, Shi Y, et al. Evidence of extensive atherosclerosis, coronary artery disease and myocardial infarction in the ApoE(−/−):Ins2(+/Akita) mouse fed a western diet. Atherosclerosis. 2018;275:88–96.CrossRef Venegas-Pino DE, Lagrotteria A, Wang PW, Morphet J, Clapdorp C, Shi Y, et al. Evidence of extensive atherosclerosis, coronary artery disease and myocardial infarction in the ApoE(−/−):Ins2(+/Akita) mouse fed a western diet. Atherosclerosis. 2018;275:88–96.CrossRef
5.
go back to reference Banerjee C, Chimowitz MI. Stroke caused by atherosclerosis of the major intracranial arteries. Circ Res. 2017;120(3):502–13.CrossRef Banerjee C, Chimowitz MI. Stroke caused by atherosclerosis of the major intracranial arteries. Circ Res. 2017;120(3):502–13.CrossRef
6.
go back to reference Ali A, Younis N, Abdallah R, Shaer F, Dakroub A, Ayoub M, et al. Lipid-Lowering therapies for atherosclerosis: statins, fibrates, ezetimibe and PCSK9 monoclonal antibodies. Curr Med Chem. 2021;28:1–18.CrossRef Ali A, Younis N, Abdallah R, Shaer F, Dakroub A, Ayoub M, et al. Lipid-Lowering therapies for atherosclerosis: statins, fibrates, ezetimibe and PCSK9 monoclonal antibodies. Curr Med Chem. 2021;28:1–18.CrossRef
7.
go back to reference Kim YH, Her AY, Jeong MH, Kim BK, Lee SY, Hong SJ, et al. Comparison between beta-blockers with angiotensin-converting enzyme inhibitors and beta-blockers with angiotensin II Type I receptor blockers in ST-segment elevation myocardial infarction after successful percutaneous coronary intervention with drug-eluting stents. Cardiovasc Drugs Ther. 2019;33(1):55–67.CrossRef Kim YH, Her AY, Jeong MH, Kim BK, Lee SY, Hong SJ, et al. Comparison between beta-blockers with angiotensin-converting enzyme inhibitors and beta-blockers with angiotensin II Type I receptor blockers in ST-segment elevation myocardial infarction after successful percutaneous coronary intervention with drug-eluting stents. Cardiovasc Drugs Ther. 2019;33(1):55–67.CrossRef
8.
go back to reference Roever LS, Resende ES, Diniz AL, Penha-Silva N, Veloso FC, Casella-Filho A, et al. Abdominal Obesity and Association With Atherosclerosis Risk Factors: The Uberlândia Heart Study. Medicine. 2016;95(11):e1357. Roever LS, Resende ES, Diniz AL, Penha-Silva N, Veloso FC, Casella-Filho A, et al. Abdominal Obesity and Association With Atherosclerosis Risk Factors: The Uberlândia Heart Study. Medicine. 2016;95(11):e1357.
9.
go back to reference Baldrighi M, Mallat Z, Li X. NLRP3 inflammasome pathways in atherosclerosis. Atherosclerosis. 2017;267:127–38.CrossRef Baldrighi M, Mallat Z, Li X. NLRP3 inflammasome pathways in atherosclerosis. Atherosclerosis. 2017;267:127–38.CrossRef
10.
go back to reference Khyzha N, Alizada A, Wilson MD, Fish JE. Epigenetics of atherosclerosis: emerging mechanisms and methods. Trends Mol Med. 2017;23(4):332–47.CrossRef Khyzha N, Alizada A, Wilson MD, Fish JE. Epigenetics of atherosclerosis: emerging mechanisms and methods. Trends Mol Med. 2017;23(4):332–47.CrossRef
11.
go back to reference Laffont B, Rayner KJ. MicroRNAs in the pathobiology and therapy of atherosclerosis. Can J Cardiol. 2017;33(3):313–24.CrossRef Laffont B, Rayner KJ. MicroRNAs in the pathobiology and therapy of atherosclerosis. Can J Cardiol. 2017;33(3):313–24.CrossRef
12.
go back to reference Fernández-Ruiz I. Atherosclerosis: a new role for lncRNAs in atherosclerosis. Nat Rev Cardiol. 2018;15(4):195.CrossRef Fernández-Ruiz I. Atherosclerosis: a new role for lncRNAs in atherosclerosis. Nat Rev Cardiol. 2018;15(4):195.CrossRef
13.
go back to reference Wang CH, Shi HH, Chen LH, Li XL, Cao GL, Hu XF. Identification of key lncRNAs associated with atherosclerosis progression based on public datasets. Front Genet. 2019;10:123.CrossRef Wang CH, Shi HH, Chen LH, Li XL, Cao GL, Hu XF. Identification of key lncRNAs associated with atherosclerosis progression based on public datasets. Front Genet. 2019;10:123.CrossRef
14.
go back to reference Pardini B, Dragomir MP. SCIRT lncRNA blocks the shot of breast cancer cells self-renewal mechanism. Can Res. 2021;81(3):535–6.CrossRef Pardini B, Dragomir MP. SCIRT lncRNA blocks the shot of breast cancer cells self-renewal mechanism. Can Res. 2021;81(3):535–6.CrossRef
15.
go back to reference Sun SG, Zheng B, Han M, Fang XM, Li HX, Miao SB, et al. miR-146a and Krüppel-like factor 4 form a feedback loop to participate in vascular smooth muscle cell proliferation. EMBO Rep. 2011;12(1):56–62.CrossRef Sun SG, Zheng B, Han M, Fang XM, Li HX, Miao SB, et al. miR-146a and Krüppel-like factor 4 form a feedback loop to participate in vascular smooth muscle cell proliferation. EMBO Rep. 2011;12(1):56–62.CrossRef
16.
go back to reference Chistiakov DA, Orekhov AN, Bobryshev YV. Vascular smooth muscle cell in atherosclerosis. Acta Physiol (Oxf). 2015;214(1):33–50.CrossRef Chistiakov DA, Orekhov AN, Bobryshev YV. Vascular smooth muscle cell in atherosclerosis. Acta Physiol (Oxf). 2015;214(1):33–50.CrossRef
Metadata
Title
LncRNA SCIRT is downregulated in atherosclerosis and suppresses the proliferation of human aortic smooth muscle cells (HAOSMCs) by sponging miR-146a in cytoplasm
Authors
Wenhui Gao
Rong Li
Jingjing Yu
Xijie He
Duo Xu
Hai Zhong
Wenwen Dong
Hanbin Cui
Publication date
01-12-2021
Publisher
BioMed Central
Published in
Journal of Cardiothoracic Surgery / Issue 1/2021
Electronic ISSN: 1749-8090
DOI
https://doi.org/10.1186/s13019-021-01700-x

Other articles of this Issue 1/2021

Journal of Cardiothoracic Surgery 1/2021 Go to the issue